Atlas Trials

A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors

Clinical trial NCT06081322 · UNKNOWN

Trial details

NCT number
NCT06081322
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Pancreatic Cancer and Cholangiocarcinoma
Start date
2023-09-01
Primary completion
2024-06-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.